Our Services
Medical Information
Helpful Resources
Published on: 5/21/2026
Recurrent hives often reflect low-grade systemic inflammation measurable with blood science markers such as CRP, ESR, CBC changes, complement proteins and cytokines, guiding more targeted treatments and ruling out serious conditions. Autoimmune antibodies may also be elevated and prompt further specialist evaluation or tailored therapies.
There are several factors to consider; see below for more important details that could affect your next healthcare steps.
Recurrent hives (also known as chronic urticaria when lasting more than six weeks) can be more than an annoying skin rash. In many cases, they reflect deeper changes in your body's immune and inflammatory systems. Understanding the link between recurrent hives systemic inflammation markers helps you and your healthcare provider find targeted treatments and rule out serious underlying conditions.
Recurrent hives appear as red, itchy welts on the skin. They may come and go daily or weekly, last minutes to hours, and move around the body. Common triggers include:
When these welts persist or recur for six weeks or longer, doctors call it chronic urticaria. In many patients, no obvious trigger is found. Instead, chronic urticaria often involves low-grade, systemic inflammation.
Inflammation is your body's way of fighting off infection, injury or harmful substances. When it becomes persistent, even at low levels, it can affect organs and tissues throughout the body. Measuring inflammation markers in the blood helps:
Below are blood tests and biomarkers commonly used to study the connection between recurrent hives and systemic inflammation markers.
Chronic urticaria can be driven by autoantibodies against:
Blood tests may include:
Positive results suggest an autoimmune basis, which often correlates with elevated systemic inflammation markers.
Research laboratories may measure specific inflammatory mediators:
Elevated levels of these cytokines have been documented in patients with recurrent hives systemic inflammation markers, reflecting ongoing immune activation.
Over time, this cycle can become self-perpetuating, leading to recurrent outbreaks that are harder to control with antihistamines alone.
Testing inflammation markers in patients with recurrent hives helps in several ways:
While blood tests guide medical treatment, simple steps can help reduce flare-ups:
If you have:
…you need more than routine testing. Before your doctor visit, you can use a free AI-powered symptom checker for Hives (Urticaria) to better understand your symptoms, identify potential triggers, and prepare informed questions for your healthcare provider.
Understanding the link between recurrent hives systemic inflammation markers and your immune system empowers you to work effectively with your healthcare team. Blood tests provide valuable clues—especially when hives refuse to go away. Always follow up abnormal results, consider specialist referral if needed, and discuss any life-threatening symptoms (like signs of anaphylaxis) with a doctor immediately. Your health matters, and the right tests and treatments can help you manage chronic urticaria and improve your quality of life.
(References)
* Kolkhir P, Hawro T, Skov PS, et al. Systemic inflammation and oxidative stress in chronic urticaria. Allergy. 2017 Mar;72(3):363-372. doi: 10.1111/all.13093. Epub 2017 Jan 3. PMID: 27803762.
* Kasperska-Zajac A, Brzoza Z, Rogala B. Prognostic and diagnostic value of inflammatory markers in chronic spontaneous urticaria. Postepy Dermatol Alergol. 2018 Dec;35(6):549-553. doi: 10.5114/ada.2018.78921. Epub 2018 Oct 31. PMID: 30635465; PMCID: PMC6322891.
* Zhao ZT, Li YY, Li XL, et al. Evaluation of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in chronic spontaneous urticaria: a systematic review and meta-analysis. Postepy Dermatol Alergol. 2018 Oct;35(5):455-460. doi: 10.5114/ada.2018.77717. Epub 2018 Aug 31. PMID: 30689979; PMCID: PMC6317765.
* Brzoza Z, Brzoza P, Kasperska-Zając A. Serum inflammatory markers in chronic spontaneous urticaria: a review. Postepy Dermatol Alergol. 2022 Feb;39(1):1-5. doi: 10.5114/ada.2022.112702. Epub 2022 Feb 2. PMID: 35136894; PMCID: PMC8823157.
* Kolkhir P, Giménez-Arnau AM, Kulthanan K, et al. Chronic urticaria: a systematic review of the roles of complement system, coagulation, and oxidative stress. Allergy. 2019 Nov;74(11):2100-2115. doi: 10.1111/all.13881. Epub 2019 Jul 24. PMID: 31338575.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.